Although it has been proven that ATG5 can be used as a poor marker of poor prognosis in early-stage ESCC patients (6), the associations among ATG5, CDKL3, PDL-1, P53, and Ki67 status in different stages of ESCC patients remains unknown in the previous publication. The gene discussed is CDKL3; the disease is esophageal squamous cell carcinoma.